AUNA

AI MemoPost-earnings T+1

Auna

As of 2026-05-19/Post-earnings T+1/Confidence low

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-05-19 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

—

Confidence

low

Horizon

—

Key catalyst

1Q26 earnings release and May 20 call provide the first full post-KPI financial readout • 2026-05-20

Expected move: +39%

Biggest risk

The bear case is that Mexico remains the weak link and the preliminary volume gains do not flow through to EBITDA or cash flow. With low coverage and no fresh post-print analyst refresh in the packet, any margin disappointment or weaker balance-sheet progress would quickly pressure the thesis.

Invalidation

Break below $4 or thesis failure.

What would change my mind?

The bull case is that the improving Peru and Colombia operating mix, plus continued Mexico stabilization, converts into higher revenue and EBITDA and makes the FY26 guidance framework credible. If the print confirms that trajectory, the stock has room to rerate from a depressed base.

Research note

Recommendation

—

Confidence

low

As of

2026-05-19

Base target

p=50%

Bull target

p=25%

Bear target

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Post-print tape should hinge on whether the KPI momentum carries into the released 1Q26 numbers
FY26 guidance and Mexico stabilization remain the real rerating path
The bull case is that the improving Peru and Colombia operating mix, plus continued Mexico stabilization, converts into higher revenue and EBITDA and makes the FY26 guidance framework credible.

BearKey bullets

FY26 guidance depends on continued commercial momentum, stable margins, and macro/regulatory conditions across Mexico, Peru, and Colombia [#PR-2026-03-10].
Leverage remained 3.6x at FY25, and deleveraging below 3x depends on EBITDA recovery and sustained free cash flow generation [#PR-2026-03-10].
Mexico demand, physician/supplier relationships, and service-line recovery may remain uneven; 4Q25 still showed softer Mexico revenue and margin pressure [#PR-2026-03-10].

WatchKey bullets

1Q26 earnings release and May 20 call provide the first full post-KPI financial readout

Summary

High-level snapshot

Recommendation

Model confidence

low

Timeframe

Asset

Equity

Trigger

Post-earnings T+1

Base case: $6 (p=50%)

Bull/Bear spread: +71% / -6%

Vs latest close: Bull +71% · Base +39% · Bear -6%

Scenario probabilities

Bull Target: $7 (p=25%)Base Target: $6 (p=50%)Bear Target: $4 (p=25%)

Commentary

Primary-source evidence confirms the earnings window, the preliminary KPI trend, and the FY26 guidance frame, but the memo remains low-conviction because the packet still lacks a fully digested earnings transcript or final filing details. No reliable immediate price-reaction or fresh analyst-revision signal is available in the evidence checked, so this is still a monitoring setup rather than a confirmed re-rating case.

As of 2026-05-19 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Post-print tape should hinge on whether the KPI momentum carries into the released 1Q26 numbers
FY26 guidance and Mexico stabilization remain the real rerating path

Scenarios

Bull Target (Scenario probability)

$7 / p=25% prob

Base Target (Scenario probability)

$6 / p=50% prob

Bear Target (Scenario probability)

$4 / p=25% prob

Price $4 as of 2026-05-27

Nearest Scenario: Bear (∆ 6%)

Targets vs latest close: Bull +71% · Base +39% · Bear -6%

Sentiment & Exposure

News Sentiment (30d)

0.00

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-05-20
1Q26 earnings release and May 20 call provide the first full post-KPI financial readout
Auna’s first-quarter 2026 release and the May 20, 2026 8:00 AM ET conference call are the hard checkpoint for revenue, EBITDA, cash flow, and balance-sheet confirmation after the preliminary operating metrics [#IR-2026-05-19] [#6K-2026-04-17].
Prob 60.00% • Move 7.00% • Priced-in 50.00%

Short-term Catalysts

Next few weeks

Post-print tape should hinge on whether the KPI momentum carries into the released 1Q26 numbers
2026-05-19
Auna’s April 17 KPI preview showed Peru surgery volumes rising to 26,428 from 24,990, Peru capacity utilization improving to 76.3% from 74.0%, OncoSalud memberships increasing to 1,439,781 from 1,364,710, and Colombia capacity utilization rising to 79.3% from 76.9%, while Mexico remained mixed with emergency treatments at 7,864 versus 8,053 [#6K-2026-04-17]. The May 19 earnings release is the near-term check on whether that operating mix translated into revenue and EBITDA quality.
Prob 55% • Move 5% • Priced-in 45%

Long-term Catalysts

Months to a year

FY26 guidance and Mexico stabilization remain the real rerating path
2026-12-31
In the March 10 FY25 release, management said Mexico showed stabilization in late 4Q25 and the first two months of 2026 and guided to approximately 12% FXN revenue and Adjusted EBITDA growth for FY26, within a 10%-14% range, with broadly stable margins and capex around 4% of revenue [#PR-2026-03-10]. If that framework holds through the next few quarters, the stock can rerate; if Mexico softens again or margins slip, the thesis weakens quickly.
Prob 52% • Move 15% • Priced-in 40%

Risks

FY26 guidance depends on continued commercial momentum, stable margins, and macro/regulatory conditions across Mexico, Peru, and Colombia [#PR-2026-03-10].
Leverage remained 3.6x at FY25, and deleveraging below 3x depends on EBITDA recovery and sustained free cash flow generation [#PR-2026-03-10].
Mexico demand, physician/supplier relationships, and service-line recovery may remain uneven; 4Q25 still showed softer Mexico revenue and margin pressure [#PR-2026-03-10].
The April 17 KPI release was explicitly preliminary, so final 1Q26 financial results can still diverge from the operating preview [#6K-2026-04-17].

Peers

Symbol	Summary
AIRS	Procedure-driven healthcare-services comp with some read-through on utilization and margin discipline, but the geography and payer mix are different enough that it is only a loose operating peer.
DCTH	Small-cap oncology-focused healthcare name; useful mainly as a sentiment and small-cap healthcare risk-appetite comparison, not as a clean operating read-through for Auna’s integrated hospital/plan model.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Human targets: serper
Analysis date: 2026-05-19

AI Stock Memo: AUNA - Auna - RankAlpha